Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director comp.
|
|
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/18/2020 |
8-K
| Director compensation was amended/approved|
Docs:
|
"Certificate of Corporate Domestication",
"Amended and Restated Certificate of Incorporation",
"Form of Assumed Warrant",
"Employment Agreement, by and between the Company and Dr. Bhat",
"Offer of Employment, by and between Marc Cantillon, MD and Reviva Pharmaceuticals, Inc",
"Letter Agreement, by and between Marc Cantillon, MD and Reviva Pharmaceuticals, Inc",
"Letter Agreement, by and between Marc Cantillon, MD and Reviva Pharmaceuticals, Inc",
"Form of Indemnification Agreement",
"Saxena Indemnification Agreement",
"Form of Non-Redemption Agreement, by and among the Company, Tenzing LLC and the shareholder party thereto" |
|
|
|